Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Unilateral motor progression in MS: Association with a critical corticospinal tract lesion.

Sechi E, Keegan BM, Kaufmann TJ, Kantarci OH, Weinshenker BG, Flanagan EP.

Neurology. 2019 Aug 13;93(7):e628-e634. doi: 10.1212/WNL.0000000000007944. Epub 2019 Jul 9.

PMID:
31289142
2.

Phases and Phenotypes of Multiple Sclerosis.

Kantarci OH.

Continuum (Minneap Minn). 2019 Jun;25(3):636-654. doi: 10.1212/CON.0000000000000737.

PMID:
31162309
3.

Investigation of white matter PiB uptake as a marker of white matter integrity.

Zeydan B, Schwarz CG, Lowe VJ, Reid RI, Przybelski SA, Lesnick TG, Kremers WK, Senjem ML, Gunter JL, Min HK, Vemuri P, Knopman DS, Petersen RC, Jack CR Jr, Kantarci OH, Kantarci K.

Ann Clin Transl Neurol. 2019 Mar 3;6(4):678-688. doi: 10.1002/acn3.741. eCollection 2019 Apr.

4.

MS progression is predominantly driven by age-related mechanisms - Commentary.

Zeydan B, Kantarci OH.

Mult Scler. 2019 Jun;25(7):906-908. doi: 10.1177/1352458518824767. Epub 2019 Feb 12. No abstract available.

PMID:
30747576
5.

Age is a critical determinant in recovery from multiple sclerosis relapses.

Conway BL, Zeydan B, Uygunoğlu U, Novotna M, Siva A, Pittock SJ, Atkinson EJ, Rodriguez M, Kantarci OH.

Mult Scler. 2018 Oct 10:1352458518800815. doi: 10.1177/1352458518800815. [Epub ahead of print]

PMID:
30303037
6.

Population-based study of "no evident disease activity" in MS.

Parks NE, Pittock SJ, Mandrekar J, Kantarci OH, Lucchinetti CF, Weinshenker BG, Keegan BM, Tobin WO, Tillema JM, Toledano M, Flanagan EP.

Neurol Neuroimmunol Neuroinflamm. 2018 Aug 16;5(6):e495. doi: 10.1212/NXI.0000000000000495. eCollection 2018 Nov.

7.

Myelin Oligodendrocyte Glycoprotein Antibody-Positive Optic Neuritis: Clinical Characteristics, Radiologic Clues, and Outcome.

Chen JJ, Flanagan EP, Jitprapaikulsan J, López-Chiriboga ASS, Fryer JP, Leavitt JA, Weinshenker BG, McKeon A, Tillema JM, Lennon VA, Tobin WO, Keegan BM, Lucchinetti CF, Kantarci OH, McClelland CM, Lee MS, Bennett JL, Pelak VS, Chen Y, VanStavern G, Adesina OO, Eggenberger ER, Acierno MD, Wingerchuk DM, Brazis PW, Sagen J, Pittock SJ.

Am J Ophthalmol. 2018 Nov;195:8-15. doi: 10.1016/j.ajo.2018.07.020. Epub 2018 Jul 26.

8.

Progressive motor impairment from a critically located lesion in highly restricted CNS-demyelinating disease.

Keegan BM, Kaufmann TJ, Weinshenker BG, Kantarci OH, Schmalstieg WF, Paz Soldan MM, Flanagan EP.

Mult Scler. 2018 Oct;24(11):1445-1452. doi: 10.1177/1352458518781979. Epub 2018 Jul 26.

PMID:
30047830
9.

Dark Rims: Novel Sequence Enhances Diagnostic Specificity in Multiple Sclerosis.

Tillema JM, Weigand SD, Dayan M, Shu Y, Kantarci OH, Lucchinetti CF, Port JD.

AJNR Am J Neuroradiol. 2018 Jun;39(6):1052-1058. doi: 10.3174/ajnr.A5636. Epub 2018 Apr 26.

10.

Occipital neuralgia associates with high cervical spinal cord lesions in idiopathic inflammatory demyelinating disease.

Kissoon NR, Watson JC, Boes CJ, Kantarci OH.

Cephalalgia. 2019 Jan;39(1):21-28. doi: 10.1177/0333102418769953. Epub 2018 Apr 8.

PMID:
29629601
11.

Cervical spinal cord atrophy: An early marker of progressive MS onset.

Zeydan B, Gu X, Atkinson EJ, Keegan BM, Weinshenker BG, Tillema JM, Pelletier D, Azevedo CJ, Lebrun-Frenay C, Siva A, Okuda DT, Kantarci K, Kantarci OH.

Neurol Neuroimmunol Neuroinflamm. 2018 Jan 22;5(2):e435. doi: 10.1212/NXI.0000000000000435. eCollection 2018 Mar.

12.

Anomalies Characteristic of Central Nervous System Demyelination: Radiologically Isolated Syndrome.

Lebrun C, Kantarci OH, Siva A, Pelletier D, Okuda DT; RISConsortium.

Neurol Clin. 2018 Feb;36(1):59-68. doi: 10.1016/j.ncl.2017.08.004. Review.

PMID:
29157404
13.

Progressive Forms of Multiple Sclerosis: Distinct Entity or Age-Dependent Phenomena.

Zeydan B, Kantarci OH.

Neurol Clin. 2018 Feb;36(1):163-171. doi: 10.1016/j.ncl.2017.08.006. Review.

PMID:
29157397
14.

Myelopathy in Behçet's disease: The Bagel Sign.

Uygunoglu U, Zeydan B, Ozguler Y, Ugurlu S, Seyahi E, Kocer N, Islak C, Kantarci K, Saip S, Siva A, Kantarci OH.

Ann Neurol. 2017 Aug;82(2):288-298. doi: 10.1002/ana.25004. Epub 2017 Aug 10.

PMID:
28749553
15.

Decreased Glutamate Levels in Patients with Amnestic Mild Cognitive Impairment: An sLASER Proton MR Spectroscopy and PiB-PET Study.

Zeydan B, Deelchand DK, Tosakulwong N, Lesnick TG, Kantarci OH, Machulda MM, Knopman DS, Lowe VJ, Jack CR Jr, Petersen RC, Öz G, Kantarci K.

J Neuroimaging. 2017 Nov;27(6):630-636. doi: 10.1111/jon.12454. Epub 2017 Jun 29.

16.

Pittsburgh compound-B PET white matter imaging and cognitive function in late multiple sclerosis.

Zeydan B, Lowe VJ, Schwarz CG, Przybelski SA, Tosakulwong N, Zuk SM, Senjem ML, Gunter JL, Roberts RO, Mielke MM, Benarroch EE, Rodriguez M, Machulda MM, Lesnick TG, Knopman DS, Petersen RC, Jack CR Jr, Kantarci K, Kantarci OH.

Mult Scler. 2018 May;24(6):739-749. doi: 10.1177/1352458517707346. Epub 2017 May 5.

17.

Timing of Future Remyelination Therapies and Their Potential to Stop Multiple Sclerosis Progression.

Zeydan B, Rodriguez M, Kantarci OH.

Adv Exp Med Biol. 2017;958:161-170. doi: 10.1007/978-3-319-47861-6_10.

PMID:
28093713
18.

Progressive solitary sclerosis: Gradual motor impairment from a single CNS demyelinating lesion.

Keegan BM, Kaufmann TJ, Weinshenker BG, Kantarci OH, Schmalstieg WF, Paz Soldan MM, Flanagan EP.

Neurology. 2016 Oct 18;87(16):1713-1719. Epub 2016 Sep 16.

19.

The contemporary spectrum of multiple sclerosis misdiagnosis: A multicenter study.

Solomon AJ, Bourdette DN, Cross AH, Applebee A, Skidd PM, Howard DB, Spain RI, Cameron MH, Kim E, Mass MK, Yadav V, Whitham RH, Longbrake EE, Naismith RT, Wu GF, Parks BJ, Wingerchuk DM, Rabin BL, Toledano M, Tobin WO, Kantarci OH, Carter JL, Keegan BM, Weinshenker BG.

Neurology. 2016 Sep 27;87(13):1393-9. doi: 10.1212/WNL.0000000000003152. Epub 2016 Aug 31.

20.

A new dawn for genetic association studies in multiple sclerosis.

Kantarci OH.

Neurol Genet. 2016 Aug 4;2(4):e93. doi: 10.1212/NXG.0000000000000093. eCollection 2016 Aug.

21.

Infliximab is a plausible alternative for neurologic complications of Behçet disease.

Zeydan B, Uygunoglu U, Saip S, Demirci ON, Seyahi E, Ugurlu S, Hamuryudan V, Siva A, Kantarci OH.

Neurol Neuroimmunol Neuroinflamm. 2016 Jul 8;3(5):e258. doi: 10.1212/NXI.0000000000000258. eCollection 2016 Oct.

22.

Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls.

Chen J, Chia N, Kalari KR, Yao JZ, Novotna M, Paz Soldan MM, Luckey DH, Marietta EV, Jeraldo PR, Chen X, Weinshenker BG, Rodriguez M, Kantarci OH, Nelson H, Murray JA, Mangalam AK.

Sci Rep. 2016 Jun 27;6:28484. doi: 10.1038/srep28484.

23.

Primary Progressive Multiple Sclerosis Evolving From Radiologically Isolated Syndrome.

Kantarci OH, Lebrun C, Siva A, Keegan MB, Azevedo CJ, Inglese M, Tintoré M, Newton BD, Durand-Dubief F, Amato MP, De Stefano N, Sormani MP, Pelletier D, Okuda DT.

Ann Neurol. 2016 Feb;79(2):288-94. doi: 10.1002/ana.24564. Epub 2015 Dec 29.

PMID:
26599831
24.

Naturally Occurring Monoclonal Antibodies and Their Therapeutic Potential for Neurologic Diseases.

Wootla B, Watzlawik JO, Warrington AE, Wittenberg NJ, Denic A, Xu X, Jordan LR, Papke LM, Zoecklein LJ, Pierce ML, Oh SH, Kantarci OH, Rodriguez M.

JAMA Neurol. 2015 Nov;72(11):1346-53. doi: 10.1001/jamaneurol.2015.2188. Review.

PMID:
26389734
25.

Poor early relapse recovery affects onset of progressive disease course in multiple sclerosis.

Novotna M, Paz Soldán MM, Abou Zeid N, Kale N, Tutuncu M, Crusan DJ, Atkinson EJ, Siva A, Keegan BM, Pirko I, Pittock SJ, Lucchinetti CF, Noseworthy JH, Weinshenker BG, Rodriguez M, Kantarci OH.

Neurology. 2015 Aug 25;85(8):722-9. doi: 10.1212/WNL.0000000000001856. Epub 2015 Jul 24. Erratum in: Neurology. 2015 Oct 13;85(15):1355.

26.

Relapses and disability accumulation in progressive multiple sclerosis.

Paz Soldán MM, Novotna M, Abou Zeid N, Kale N, Tutuncu M, Crusan DJ, Atkinson EJ, Siva A, Keegan BM, Pirko I, Pittock SJ, Lucchinetti CF, Weinshenker BG, Rodriguez M, Kantarci OH.

Neurology. 2015 Jan 6;84(1):81-8. doi: 10.1212/WNL.0000000000001094. Epub 2014 Nov 14.

27.

Idiopathic inflammatory demyelinating disease of the central nervous system in patients with inflammatory bowel disease: retrospective analysis of 9095 patients.

De Felice KM, Novotna M, Enders FT, Faubion WA, Tremaine WJ, Kantarci OH, Raffals LE.

Aliment Pharmacol Ther. 2015 Jan;41(1):99-107. doi: 10.1111/apt.12997. Epub 2014 Oct 27.

28.

When Drinking Makes the Tremor Worse: A Task-Specific Orolingual Tremor.

O'Gorman CM, Bower JH, Matsumoto JY, Kantarci OH, Kumar N.

Mov Disord Clin Pract. 2014 Jun 4;1(3):237-239. doi: 10.1002/mdc3.12041. eCollection 2014 Sep. No abstract available.

29.

Teaching neuroimages: MRI in advanced neuromyelitis optica.

Braksick SA, Cutsforth-Gregory JK, Black DF, Weinshenker BG, Pittock SJ, Kantarci OH.

Neurology. 2014 Mar 25;82(12):e101-2. doi: 10.1212/WNL.0000000000000246. No abstract available.

PMID:
24663236
30.

Novel immunomodulatory approaches for the management of multiple sclerosis.

Kantarci OH, Pirko I, Rodriguez M.

Clin Pharmacol Ther. 2014 Jan;95(1):32-44. doi: 10.1038/clpt.2013.196. Epub 2013 Oct 30. Review.

PMID:
24173041
31.

Amyloid-β-related angiitis presenting as a uveomeningeal syndrome.

Child ND, Braksick SA, Flanagan EP, Keegan BM, Giannini C, Kantarci OH.

Neurology. 2013 Nov 12;81(20):1796-8. doi: 10.1212/01.wnl.0000435560.00234.a7. Epub 2013 Oct 16.

PMID:
24132378
32.

Fulminant cerebellitis with radiological recurrence in an adult patient with Crohn's disease.

Flanagan EP, Rabinstein AA, Kumar N, Schroeder K, Kantarci OH.

J Neurol Sci. 2014 Jan 15;336(1-2):247-50. doi: 10.1016/j.jns.2013.09.017. Epub 2013 Sep 20.

PMID:
24090762
33.

Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis.

Tutuncu M, Tang J, Zeid NA, Kale N, Crusan DJ, Atkinson EJ, Siva A, Pittock SJ, Pirko I, Keegan BM, Lucchinetti CF, Noseworthy JH, Rodriguez M, Weinshenker BG, Kantarci OH.

Mult Scler. 2013 Feb;19(2):188-98. doi: 10.1177/1352458512451510. Epub 2012 Jun 26.

34.

A 21-year-old woman with multiple cancers and a new brain lesion.

Schiff D, Lam EM, Parisi JE, Giannini C, Uhm JH, Keegan BM, Kantarci OH.

Neurology. 2012 Mar 6;78(10):743-9. doi: 10.1212/WNL.0b013e318248e59c. No abstract available.

PMID:
22391604
35.

N-methyl-D-aspartate receptor autoimmune encephalitis presenting with opsoclonus-myoclonus: treatment response to plasmapheresis.

Smith JH, Dhamija R, Moseley BD, Sandroni P, Lucchinetti CF, Lennon VA, Kantarci OH.

Arch Neurol. 2011 Aug;68(8):1069-72. doi: 10.1001/archneurol.2011.166.

PMID:
21825245
36.

Intravascular lymphoma presenting as a longitudinally-extensive myelitis: diagnostic challenges and etiologic clues.

Kumar N, Keegan BM, Rodriguez FJ, Hammack JE, Kantarci OH.

J Neurol Sci. 2011 Apr 15;303(1-2):146-9. doi: 10.1016/j.jns.2010.12.016. Epub 2011 Jan 17.

PMID:
21247588
37.

Association of IL2RA polymorphisms with susceptibility to multiple sclerosis is not explained by missense mutations in IL2RA.

Matiello M, Weinshenker BG, Atkinson EJ, Schaefer-Klein J, Kantarci OH.

Mult Scler. 2011 May;17(5):634-6. doi: 10.1177/1352458510394703. Epub 2011 Jan 14. Erratum in: Mult Scler. 2016 Oct;22(11):NP5.

PMID:
21239413
38.

Sex-stratified inheritance of MS: new horizons from studies in MHC region.

Kantarci OH.

Neurology. 2011 Jan 18;76(3):210-2. doi: 10.1212/WNL.0b013e3182074c1e. Epub 2011 Jan 5. No abstract available.

PMID:
21209375
39.

A patient with established primary progressive multiple sclerosis transitions to 'secondary' relapsing-remitting disease course following a fulminant demyelinating episode.

Tutuncu M, Demirci NO, Özer F, Saip S, Kantarci OH, Siva A.

Mult Scler. 2011 Oct;17(10):1262-4. doi: 10.1177/1352458510387183. Epub 2010 Dec 6.

PMID:
21135019
40.

HLA-DRB1*1501 tagging rs3135388 polymorphism is not associated with neuromyelitis optica.

Matiello M, Schaefer-Klein J, Brum DG, Atkinson EJ, Kantarci OH, Weinshenker BG; NMO genetics collaborators.

Mult Scler. 2010 Aug;16(8):981-4. doi: 10.1177/1352458510374340. Epub 2010 Jun 30.

PMID:
20591987
41.

Treatment of neuromyelitis optica with mycophenolate mofetil: retrospective analysis of 24 patients.

Jacob A, Matiello M, Weinshenker BG, Wingerchuk DM, Lucchinetti C, Shuster E, Carter J, Keegan BM, Kantarci OH, Pittock SJ.

Arch Neurol. 2009 Sep;66(9):1128-33. doi: 10.1001/archneurol.2009.175.

PMID:
19752302
42.

A 54-year-old woman with progressive gait disturbance and MRI abnormalities.

Hochberg FH, Rodriguez FJ, Atkinson JL, Shaw EG, Keegan BM, Kantarci OH.

Neurology. 2009 Aug 11;73(6):466-74. doi: 10.1212/WNL.0b013e3181b1644d. No abstract available.

PMID:
19667322
43.

Multiple sclerosis risk in radiologically uncovered asymptomatic possible inflammatory-demyelinating disease.

Siva A, Saip S, Altintas A, Jacob A, Keegan BM, Kantarci OH.

Mult Scler. 2009 Aug;15(8):918-27. doi: 10.1177/1352458509106214.

PMID:
19667020
44.

Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders.

Magaña SM, Matiello M, Pittock SJ, McKeon A, Lennon VA, Rabinstein AA, Shuster E, Kantarci OH, Lucchinetti CF, Weinshenker BG.

Neurology. 2009 Feb 24;72(8):712-7. doi: 10.1212/01.wnl.0000343001.36493.ae.

PMID:
19237699
45.

Parent of origin in multiple sclerosis: understanding inheritance in complex neurologic diseases.

Kantarci OH, Spurkland A.

Neurology. 2008 Sep 9;71(11):786-7. doi: 10.1212/01.wnl.0000325476.61600.2b. No abstract available.

PMID:
18779508
46.

Interferon gamma allelic variants: sex-biased multiple sclerosis susceptibility and gene expression.

Kantarci OH, Hebrink DD, Schaefer-Klein J, Sun Y, Achenbach S, Atkinson EJ, Heggarty S, Cotleur AC, de Andrade M, Vandenbroeck K, Pelfrey CM, Weinshenker BG.

Arch Neurol. 2008 Mar;65(3):349-57. doi: 10.1001/archneurol.2007.66.

PMID:
18332247
47.

Genetics and natural history of multiple sclerosis.

Kantarci OH.

Semin Neurol. 2008 Feb;28(1):7-16. doi: 10.1055/s-2007-1019125. Review.

PMID:
18256983
48.

Ornithine transcarbamylase deficiency presenting as encephalopathy during adulthood following bariatric surgery.

Hu WT, Kantarci OH, Merritt JL 2nd, McGrann P, Dyck PJ, Lucchinetti CF, Tippmann-Peikert M.

Arch Neurol. 2007 Jan;64(1):126-8.

PMID:
17210820
49.

Men transmit MS more often to their children vs women: the Carter effect.

Kantarci OH, Barcellos LF, Atkinson EJ, Ramsay PP, Lincoln R, Achenbach SJ, De Andrade M, Hauser SL, Weinshenker BG.

Neurology. 2006 Jul 25;67(2):305-10.

PMID:
16864824
50.

CCR5Delta32 polymorphism effects on CCR5 expression, patterns of immunopathology and disease course in multiple sclerosis.

Kantarci OH, Morales Y, Ziemer PA, Hebrink DD, Mahad DJ, Atkinson EJ, Achenbach SJ, De Andrade M, Mack M, Ransohoff RM, Lassmann H, Bruck W, Weinshenker BG, Lucchinetti CF.

J Neuroimmunol. 2005 Dec;169(1-2):137-43. Epub 2005 Sep 22.

PMID:
16182378

Supplemental Content

Loading ...
Support Center